HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Tarte

This article was originally published in The Rose Sheet

Executive Summary

Suede compact collection for fall comprises three eyeshadows in Grace (silvery white), Sultry (charcoal) and Vixen (copper) and one cheek compact in Charisma (dusty pink). Eyeshadows and cheek compact will retail for $16 and $19, respectively. Four lipstick shades Cabernet, Zinfindel, Chianti and Pinot Noir, also will debut for fall. Four new double-ended lip glosses - Bonnie & Clyde, Ricky & Lucy, Harry & Sally and Tarzan & Jane - will debut in Henri Bendel, Fred Segal, E6 Apothecary and on Beauty.com Sept. 1. Tarte cosmetics line originally launched last year (1"The Rose Sheet" July 31, 2000, p. 8)

You may also be interested in...



Tarte Cosmetics Line Sweetens Bendel, Beauty.com Stables

Tarte cosmetics line, the latest makeup artist entry preparing to hit the market, will debut exclusively at Henri Bendel and on Beauty.com Sept. 1 as part of a limited distribution plan.

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Beauty Claims Inch Closer To Pharma As Cosmeceutical Sector Expands

Though global market-size estimates differ, analysts at SupplySide West 2010 in Las Vegas agreed that cosmeceuticals remain a promising growth vehicle

Latest Headlines
See All
UsernamePublicRestriction

Register

RS009501

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel